A federal judge overseeing the Provigil antitrust litigation has awarded attorneys representing end-payers nearly $22 million in fees.

U.S. District Judge Mitchell Goldberg of the Eastern District of Pennsylvania awarded $21.9 million to lead plaintiffs attorneys, including Kevin Love of Criden & Love in South Miami, who represent consumers and companies that paid for the drug after Cephalon.